RE:RE:Evolution - 3rd phaseYou do know that a company cannot "reward" its shareholders with a higher stock price, right? The price of the stock is determined by the market. The only thing a company can do is to make intelligent decisions that increase shareholder value in the long run.
Eventually, the price of the stock will follow. "Eventually" may be months or years. That's not always fun when you own a bunch of shares. On the other hand, it sometimes gives you the opportunity to buy more stock at very attractive prices.
If you think a company like GBT is worthless in the hands of Goodman and the team, I have no idea why would have invested in GUD in the first place. Furthermore, now is not the time to complain about the company failing to make progress:
1) Knight has made a big entry into the LATAM market. This is a big deal for many reasons! The integration of GBT companies is still a year from being completed.
2) Knight has several products/markets in submitted, approved or early launch phases (see page 27 of the latest annual report).
3) Knight has Goodman and his team with almost $400M of cash, cash equivalents and marketable securities. They will use this money for new launches, product and product portfolio acquisitions, in-licensing of drugs, branded generic drug development, bolt-on acquisitions, and strategic loans. They will make intelligent decisions with the money.
Exciting times! :)